Management of High PVC Burden
Risk Assessment and Implications
- A PVC burden of 19.4% significantly exceeds the threshold (>10-15%) associated with development of PVC-induced cardiomyopathy, placing a patient at high risk for left ventricular dysfunction 3, 4
- PVC burden ≥24% is independently associated with cardiomyopathy, but even burdens >10% can result in cardiomyopathy, making this 19.4% burden clinically significant 4
- This high burden increases risk of left ventricular dysfunction and cardiomyopathy 1, 4
Treatment Algorithm
- The American College of Cardiology recommends catheter ablation as the most effective treatment to reduce PVCs and prevent or reverse PVC-induced cardiomyopathy, especially when this high burden is causing symptoms or declining ventricular function 1, 2
- Catheter ablation has success rates of up to 80% and can normalize left ventricular ejection fraction within 6 months in 82% of patients with depressed ventricular function 1, 4
- Beta-blockers or amiodarone are reasonable to reduce recurrent arrhythmias and improve symptoms and LV function 1, 5
Monitoring and Follow-up
- The American College of Cardiology recommends assessing for improvement in PVC burden after initiating therapy and following LV function with serial echocardiography to document improvement if there is evidence of cardiomyopathy 1, 5
- If catheter ablation is performed, continue monitoring as recurrence risk remains substantial after an apparently successful procedure 1
Important Clinical Considerations
- It can be challenging to determine whether PVCs caused LV dysfunction or whether progressive LV dysfunction caused frequent PVCs 1
- The right ventricular outflow tract is the most common origin of PVCs (52% of cases), which may inform ablation approach 4
- Patients who do not respond to radiofrequency ablation may experience progression of cardiomyopathy 4
Pitfalls to Avoid
- Delaying treatment in patients with high PVC burden (>15%) even if asymptomatic, as they remain at risk for developing cardiomyopathy 4
- Failing to monitor LV function in patients with high PVC burden, even after successful treatment 5
- Overlooking other causes of cardiomyopathy that may coexist with frequent PVCs 4